About: Factors that influence collection and engraftment of autologous peripheral-blood stem cells

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Factors that influence collection and engraftment of autologous peripheral-blood stem cells Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 1995

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 1995 (uk) article scientifique publié en 1995 (fr) im Oktober 1995 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'ochobre de 1995 (ast) scientific article published on 01 October 1995 (en)
publication date	wds:Q71832943-36BA856F-5F59-42D3-9520-EE7E50837996
publication date	1995-10-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q71832943-4F723CC8-044E-45F6-BA1D-47CAC1D10DF2
language of work or name	English
author name string	wds:Q71832943-153C8A05-70EA-441C-9109-8432BE88441C wds:Q71832943-23E2B21F-5F2A-41C7-88A9-1A3774097E3D wds:Q71832943-73EBD4F4-DB58-4CC1-BAF9-FA568B27DDC1 wds:Q71832943-797EFED3-B117-4F53-ABA4-DB72A8458D39 wds:Q71832943-986562B8-CD1F-4749-B302-176D568F2ED7 wds:Q71832943-CB6A82A1-B732-4AEB-8553-92BA98B05B01 wds:Q71832943-CE85726E-E32C-45B6-81D7-C0119718C2FA wds:Q71832943-E5E31E02-C217-4430-9330-E2F14AA24B13
author name string	J Sanders T Demirer T Gooley W Bensinger S Rowley K Lilleby C Weaver K Schiffman
rdfs:label	Factors that influence collection and engraftment of autologous peripheral-blood stem cells (en) Factors that influence collection and engraftment of autologous peripheral-blood stem cells (nl)
skos:prefLabel	Factors that influence collection and engraftment of autologous peripheral-blood stem cells (en) Factors that influence collection and engraftment of autologous peripheral-blood stem cells (nl)
name	Factors that influence collection and engraftment of autologous peripheral-blood stem cells (en) Factors that influence collection and engraftment of autologous peripheral-blood stem cells (nl)
author	wds:Q71832943-2577106C-371C-49BA-AE74-2FFD75C00583 wds:Q71832943-884E6B8A-3FED-4265-82FA-8D024342F982
author	Frederick R. Appelbaum Rainer Storb
title	wds:Q71832943-4E25572C-6256-4D33-B3AC-1CDE9593946E
title	Factors that influence collection and engraftment of autologous peripheral-blood stem cells (en)
page(s)	wds:Q71832943-EFFA70A1-2E3A-4F35-8251-DCDE120AE6A5
page(s)	2547-2555
instance of	wds:Q71832943-53EF9181-F698-4EEA-A41C-38EF5DC175F3
instance of	scholarly article
PubMed ID	wds:Q71832943-BB98ED20-B9AD-4ED7-AAB1-139954610314
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7595706
PubMed ID	7595706
published in	wds:Q71832943-A6A08A50-6F98-4EF6-B610-B195C96B5EA3
published in	Journal of Clinical Oncology
issue	wds:Q71832943-F5C229FE-5BC1-41E6-8623-6DBF5EEC4A54
volume	wds:Q71832943-E8A904B8-2F7A-4340-96A1-E2D7CDCEE0CD
issue	10
volume	13
DOI	wds:Q71832943-037159C4-9DD0-4213-9EAE-154AACE3256E
DOI	http://dx.doi.org/10.1200/JCO.1995.13.10.2547
DOI	10.1200/JCO.1995.13.10.2547
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71832943
is cites work of	Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma Pegfilgrastim vs filgrastim in PBSC mobilization for autologous hematopoietic SCT: a systematic review and meta-analysis Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas Analysis of parameters affecting engraftment in children undergoing autologous peripheral blood stem cell transplants Improving stem cell mobilization strategies: future directions A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation Predictive factors for successful stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine Epo and other hematopoietic factors Four-step high-dose sequential chemotherapy with hematopoietic progenitor-cell support as induction treatment for patients with solid tumors Using peripheral blood progenitor cells (PBPC) for transplantation in pediatric patients: a state-of-the-art review Effects of aging on the homing and engraftment of murine hematopoietic stem and progenitor cells Pegfilgrastim after high-dose chemotherapy and autologous peripheral blood stem cell transplant: phase II study. Combination of intensive chemotherapy and anticancer vaccines in the treatment of human malignancies: the hematological experience Blood or marrow? Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma Analysis of remobilization success in patients undergoing autologous stem cell transplants who fail an initial mobilization: risk factors, cytokine use and cost. Clinical experience with a simple algorithm for plerixafor utilization in autologous stem cell mobilization. Plerixafor: a review of its use in stem-cell mobilization in patients with lymphoma or multiple myeloma Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: a randomized, controlled trial Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor Factors influencing the collection of peripheral blood stem cells in patients with acute myeloblastic leukemia and non-myeloid malignancies A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100). Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobilizers The whys and hows of hematopoietic progenitor and stem cell mobilization Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim The CD3- 16+ 56+ NK cell count independently predicts autologous blood stem cell mobilization Influence of CD34+ marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia Timing of platelet recovery is associated with adequacy of leukapheresis product yield after cyclophosphamide and G-CSF in patients with lymphoma DCEP (dexamethasone, cyclophosphamide, etoposide, and cisplatin) is an effective regimen for peripheral blood stem cell collection in multiple myeloma Plerixafor Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomised trial Integration of a hematopoietic progenitor cell program using the ACT/DB database system. The role of pegfilgrastim in mobilization of hematopoietic stem cells Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow Busulfan, melphalan, and thiotepa with or without total marrow irradiation with hematopoietic stem cell rescue for poor-risk Ewing-Sarcoma-Family tumors Ifosamide, epirubicin and granulocyte colony-stimulating factor: a regimen for successful mobilization of peripheral blood progenitor cells in patients with multiple myeloma Blood stem cell collections in multiple myeloma: definition of a scoring system Early total white blood cell recovery is a predictor of low number of apheresis and good CD34(+) cell yield A comparison of toxicity following two different doses of cyclophosphamide for mobilization of peripheral blood progenitor cells in 116 multiple myeloma patients Factors impacting stem cell mobilization failure rate and efficiency in multiple myeloma in the era of novel therapies: experience at Memorial Sloan Kettering Cancer Center. Predicting the successful peripheral blood stem cell harvesting. A randomized phase III clinical trial of autologous blood stem cell transplantation comparing cryopreservation using dimethylsulfoxide vs dimethylsulfoxide with hydroxyethylstarch Similar response rates and superior early progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplan

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software